Jesse Shefferman - 29 Jun 2026 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
01 Jul 2026, 16:10:10 UTC
Prior SEC filing
27 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jesse Shefferman

Key filing fact

Jesse Shefferman filed Form 4 for Protara Therapeutics, Inc. (TARA) on 01 Jul 2026.

Key facts

  • This page summarizes Jesse Shefferman's Form 4 filing for Protara Therapeutics, Inc. (TARA).
  • 7 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 01 Jul 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 27 Jan 2026.
  • Current net transaction value: -$882,160.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001799167 Primary reporting owner

Shefferman Jesse

Relationship
CEO and President, Director
Address
C/O PROTARA THERAPEUTICS, INC., 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK
Signature
/s/ Jesse Shefferman
Signature date
01 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TARA transaction

Common Stock

Options Exercise

Transaction value
Shares
+215,687
Change %
+30%
Price
$1.91*
Shares after
937,519
Date
29 Jun 2026
Ownership
Direct
TARA transaction

Common Stock

Sale

Transaction value
$882,160
Shares
-215,687
Change %
-23%
Price
$4.09
Shares after
721,832
Date
29 Jun 2026
Ownership
Direct
Footnotes
F1
TARA transaction

Common Stock

Gift

Transaction value
Shares
-14,000
Change %
-1.9%
Price
$0.000000*
Shares after
707,832
Date
30 Jun 2026
Ownership
Direct
TARA transaction

Common Stock

Gift

Transaction value
Shares
-7,000
Change %
-0.99%
Price
$0.000000*
Shares after
700,832
Date
30 Jun 2026
Ownership
Direct
TARA transaction

Common Stock

Gift

Transaction value
Shares
-4,000
Change %
-0.57%
Price
$0.000000*
Shares after
696,832
Date
30 Jun 2026
Ownership
Direct
TARA transaction

Common Stock

Gift

Transaction value
Shares
-5,000
Change %
-0.72%
Price
$0.000000*
Shares after
691,832
Date
30 Jun 2026
Ownership
Direct
TARA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
300,000
Date
29 Jun 2026
Ownership
The Samhold Family Trust
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TARA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-215,687
Change %
-60%
Price
$0.000000*
Shares after
141,313
Date
29 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
215,687
Exercise price
$1.91
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.03 to $4.14, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F2

The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest, and this report should not be deemed an admission that the Reporting Person or any other person named herein is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Footnote F3

The reported securities held by the Samhold Family Trust were inadvertently included under the Reporting Person's direct holdings in the prior Form 4 filings filed by the Reporting Person on January 21, 2026, January 22, 2026 and January 27, 2026.

Footnote F4

25% of the shares underlying the option vested on January 19, 2025 and the remaining shares have vested or will vest in equal monthly installments thereafter over the following 36 months, subject to the Reporting Person's continuous service with the Issuer as of each such date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .